{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T09:02:21Z","timestamp":1723280541810},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/jp.2008.160","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T10:45:31Z","timestamp":1228473931000},"page":"S72-S78","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacotherapy for meconium aspiration"],"prefix":"10.1038","volume":"28","author":[{"given":"A","family":"Asad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,5]]},"reference":[{"key":"BFjp2008160_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1651-2227.2001.tb01626.x","volume":"436","author":"TM Wiswell","year":"2001","unstructured":"Wiswell TM . Advances in treatment of the meconium aspiration syndrome. Acta Paediatr Suppl 2001; 436: 28\u201330.","journal-title":"Acta Paediatr Suppl"},{"key":"BFjp2008160_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.105.1.1","volume":"105","author":"TE Wiswell","year":"2000","unstructured":"Wiswell TE . Meconium in the Delivery Room Trial Group: delivery room management of the apparently vigorous meconium-stained neonate: results of the multicenter collaborative trial. Pediatrics 2000; 105: 1\u20137.","journal-title":"Pediatrics"},{"key":"BFjp2008160_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0022-3476(88)80183-5","volume":"112","author":"N Linder","year":"1988","unstructured":"Linder N, Aranda JV, Tsur M . Need for endotracheal intubation and suction in meconium-stained neonates. J Pediatr 1988; 112: 613\u2013615.","journal-title":"J Pediatr"},{"key":"BFjp2008160_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0022-3476(05)81102-3","volume":"117","author":"R Bhat","year":"1990","unstructured":"Bhat R, Chari G, Gulati A, Aldana O, Velamati R, Bhargava H . Pharmacokinetics of Morphine in preterm and term neonates. J Pediatr 1990; 117: 477\u2013481.","journal-title":"J Pediatr"},{"key":"BFjp2008160_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0022-3476(05)80251-3","volume":"120","author":"R Bhat","year":"1992","unstructured":"Bhat R, Abu-Harb M, Chari G, Gulati A . Morphine metabolism in acutely ill preterm newborn infants. J Pediatr 1992; 120: 795\u2013799.","journal-title":"J Pediatr"},{"key":"BFjp2008160_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1542\/peds.105.1.14","volume":"105","author":"MC Walsh-Sukys","year":"2000","unstructured":"Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics 2000; 105: 14\u201320.","journal-title":"Pediatrics"},{"key":"BFjp2008160_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1203\/00006450-198512000-00009","volume":"19","author":"RK Lyrene","year":"1985","unstructured":"Lyrene RK, Welch KA, Godoy G, Philips III JB . Alkalosis attenuates hypoxic pulmonary vasoconstriction in neonatal lambs. Pediatr Res 1985; 19: 1268\u20131271.","journal-title":"Pediatr Res"},{"key":"BFjp2008160_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0022-3476(81)80775-5","volume":"98","author":"WH Drummond","year":"1981","unstructured":"Drummond WH, Gregory GA, Heymann MA, Phibbs RA . The independent effects of hyperventilation, tolazoline, and dopamine in infants with persistent pulmonary hypertension. J Pediatr 1981; 98: 608\u2013611.","journal-title":"J Pediatr"},{"issue":"11","key":"BFjp2008160_CR9","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1203\/00006450-198411000-00015","volume":"18","author":"NB Hansen","year":"1984","unstructured":"Hansen NB, Brubakk AM, Bratlid D, Oh W, Stonestreet BS . The effects of variations in PaCO2 on brain blood flow and cardiac output in the newborn piglet. Pediatr Res 1984; 18 (11): 1132\u20131136.","journal-title":"Pediatr Res"},{"issue":"3","key":"BFjp2008160_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0095-5108(05)70104-4","volume":"28","author":"N Ambalavanan","year":"2001","unstructured":"Ambalavanan N, Carlo WA . Hypocapnia and hypercapnia in respiratory management of newborn infants. Clin Perinatol 2001; 28 (3): 517\u2013531. Review.","journal-title":"Clin Perinatol"},{"issue":"2","key":"BFjp2008160_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.prrv.2005.03.005","volume":"6","author":"A Greenough","year":"2005","unstructured":"Greenough A, Khetriwal B . Pulmonary hypertension in the newborn. Paediatr Respir Rev 2005; 6 (2): 111\u2013116.","journal-title":"Paediatr Respir Rev"},{"issue":"4","key":"BFjp2008160_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/bja\/74.4.419","volume":"74","author":"PD Booker","year":"1995","unstructured":"Booker PD, Evans C, Franks R . Comparison of the haemodynamic effects of dopamine and dobutamine in young children undergoing cardiac surgery. Br J Anaesth 1995; 74 (4): 419\u2013423.","journal-title":"Br J Anaesth"},{"key":"BFjp2008160_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0022-3476(79)80777-5","volume":"95","author":"DK Stevenson","year":"1979","unstructured":"Stevenson DK, Kasting DS, Darnall Jr RA, Ariagno RL, Johnson JD, Malachowski N et al. Refractory hypoxemia associated with neonatal pulmonary diseases: the use and limitations of tolazoline. J Pediatr 1979; 95: 595\u2013599.","journal-title":"J Pediatr"},{"issue":"5","key":"BFjp2008160_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1542\/peds.109.5.852","volume":"109","author":"P Nuntnarumit","year":"2002","unstructured":"Nuntnarumit P, Korones SB, Yang W, Bada HS . Efficacy and safety of tolazoline for treatment of severe hypoxemia in extremely preterm infants. Pediatrics 2002; 109 (5): 852\u2013856.","journal-title":"Pediatrics"},{"key":"BFjp2008160_CR15","first-page":"461","volume":"17","author":"SK Parida","year":"1997","unstructured":"Parida SK, Baker S, Kuhn R, Desai N, Pauly TH . Endotracheal tolazoline administration in neonates with persistent pulmonary hypertension. J Perinatol 1997; 17: 461\u2013464.","journal-title":"J Perinatol"},{"key":"BFjp2008160_CR16","doi-asserted-by":"publisher","first-page":"F184","DOI":"10.1136\/fn.72.3.F184","volume":"72","author":"JF Tolsa","year":"1995","unstructured":"Tolsa JF, Cotting J, Sekarski N, Payot M, Micheli JL, Calame A . Magensium Sulphate as an alternative and safe treatment for persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed 1995; 72: F184\u2013F187.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFjp2008160_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/S0022-3468(99)90361-5","volume":"34","author":"S Islam","year":"1999","unstructured":"Islam S, Masiakos P, Schnitzer JJ, Doody DP, Ryan DP . Diltiazem reduces pulmonary arterial pressures in recurrent pulmonary hypertension associated with pulmonary hypoplasia. J Pediatr Surg 1999; 34: 712\u2013714.","journal-title":"J Pediatr Surg"},{"key":"BFjp2008160_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/BF01699234","volume":"22","author":"S Al-Alaiyan","year":"1996","unstructured":"Al-Alaiyan S, Al-Omran A, Dyer D . The use of phoshodiestersae inhibitor( dipyridamole) to wean from inhaled nitric oxide. Intensive care med 1996; 22: 1093\u20131095.","journal-title":"Intensive care med"},{"key":"BFjp2008160_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0022-5223(98)70369-1","volume":"115","author":"DD Ivy","year":"1998","unstructured":"Ivy DD, Kinsella JP, Ziegler JW, Abman SH . Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawl in postoperative congenital heart disease. J Thorac Cardiovasc Surg 1998; 115: 875\u2013882.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"BFjp2008160_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0140-6736(95)91487-0","volume":"346","author":"JP Kinsella","year":"1995","unstructured":"Kinsella JP, Toricelli F, Ziegler JW, Ivy DD, Abman SH . Dipyridamole augmentation of response to nitric oxide. Lancet 1995; 346: 647\u2013648.","journal-title":"Lancet"},{"issue":"6","key":"BFjp2008160_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/ppul.10389","volume":"36","author":"JN Travadi","year":"2003","unstructured":"Travadi JN, Patole SK . Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatr Pulmonol 2003; 36 (6): 529\u2013535.","journal-title":"Pediatr Pulmonol"},{"key":"BFjp2008160_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1203\/01.PDR.0000134257.20214.57","volume":"56","author":"LS Shekerdamien","year":"2004","unstructured":"Shekerdamien LS, Penny DJ, Ryhammer PK, Reader JA, Ravn HB . Endothelin\u2014a receptor blockade and inhaled nitric oxide in a porcine model of meconium aspiration syndrome. Pediatr Res 2004; 56: 353\u2013358.","journal-title":"Pediatr Res"},{"issue":"9","key":"BFjp2008160_CR23","first-page":"1243","volume":"20","author":"D Schranz","year":"1992","unstructured":"Schranz D, Zepp F, Iversen S, Wippermann C, Huth R, Zimmer B et al. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery. Crit Care Med 1992; 20 (9): 1243\u20131249.","journal-title":"Crit Care Med"},{"issue":"2","key":"BFjp2008160_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/hrt.60.2.141","volume":"60","author":"A Bush","year":"1988","unstructured":"Bush A, Busst CM, Knight WB, Shinebourne EA . Comparison of the haemodynamic effects of epoprostenol (prostacyclin) and tolazoline. Br Heart J 1988; 60 (2): 141.","journal-title":"Br Heart J"},{"key":"BFjp2008160_CR25","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1183\/09031936.98.12040932","volume":"12","author":"AP De Jaeger","year":"1998","unstructured":"De Jaeger AP, den Anker JN . Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension. Eur Respir J 1998; 12: 932\u2013934.","journal-title":"Eur Respir J"},{"key":"BFjp2008160_CR26","doi-asserted-by":"publisher","first-page":"F204","DOI":"10.1136\/adc.2005.092817","volume":"92","author":"M Paradisis","year":"2007","unstructured":"Paradisis M, Jiang X, Mclachlan AJ, Evans N, Kluckow M, Osborn D . Population pharmacokinetics and dosing regimen of milrinone in preterm infants. Arch Dis Child Fetal Neonatal Ed 2007; 92: F204\u2013F209.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFjp2008160_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1542\/peds.2005-0523","volume":"117","author":"H Baquero","year":"2006","unstructured":"Baquero H, Soliz A, Neira F, Venegas ME, Sola A . Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006; 117: 1077\u20131083.","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"BFjp2008160_CR28","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0735-1097(02)81805-8","volume":"39","author":"S Erickson","year":"2002","unstructured":"Erickson S, Reyes J, Bohn D, Adatia I . Sildenafil (Viagra) in childhood and neonatal pulmonary hypertension. J Am Coll Cardiol 2002; 39 (Suppl 2): 402\u2013402(1).","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"BFjp2008160_CR29","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","volume":"298","author":"JJV McMurray","year":"2007","unstructured":"McMurray JJV, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G et al. Effects of Tezosentan on symptoms and clinical outcomes in patients with acute heart failure. JAMA 2007; 298 (17): 2009\u20132019.","journal-title":"JAMA"},{"key":"BFjp2008160_CR30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1542\/peds.97.3.295","volume":"97","author":"GG Konduri","year":"1996","unstructured":"Konduri GG, Garcia DC, Kazzi NJ, Shankaran S . Adenosine infusion improves oxygenation in term infants with respiratory failure. Pediatrics 1996; 97: 295\u2013300.","journal-title":"Pediatrics"},{"key":"BFjp2008160_CR31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S1053-0770(96)80098-X","volume":"10","author":"TS Lee","year":"1996","unstructured":"Lee TS, Hou X . Dual vasoactive effects of tolazoline on rabbit pulmonary arteries. J Cardiothoc Vasc Anesth 1996; 10: 364\u2013367.","journal-title":"J Cardiothoc Vasc Anesth"},{"key":"BFjp2008160_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0022-3476(96)70440-7","volume":"128","author":"J Curtis","year":"1996","unstructured":"Curtis J, Palacino JJ, O\u2019Neill JT . Production of pulmonary vasodilation by tolazoline, independent of nitric oxide production in neonatal lambs. J Pediatr 1996; 128: 118\u2013124.","journal-title":"J Pediatr"},{"key":"BFjp2008160_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2007-993827","volume":"16","author":"G Paret","year":"1999","unstructured":"Paret G, Eyal O, Mayan H, Ben-Abraham R, Vardi A, Manisterski Y et al. Pharmacokinetics of endobronchial tolazoline administration in dogs. Am J Perinatol 1999; 16: 1\u20136.","journal-title":"Am J Perinatol"},{"key":"BFjp2008160_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/hrt.73.1.99","volume":"73","author":"JC Welch","year":"1995","unstructured":"Welch JC, Bridosn JM, Gibbs JL . Endotracheal tolazoline for severe persistent pulmonary hypertension of the newborn. Br Heart J 1995; 73: 99\u2013100.","journal-title":"Br Heart J"},{"key":"BFjp2008160_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000088192","volume":"89","author":"D Bassler","year":"2006","unstructured":"Bassler D, Choong K, McNamara P, Kirpalani H . Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 2006; 89: 1\u20135.","journal-title":"Biol Neonate"},{"key":"BFjp2008160_CR36","first-page":"473","volume":"269","author":"JW Ziegler","year":"1995","unstructured":"Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH et al Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am J Physiol 1995; 269: 473\u2013479.","journal-title":"Am J Physiol"},{"key":"BFjp2008160_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1164\/ajrccm.152.5.7582302","volume":"152","author":"KG Thusu","year":"1995","unstructured":"Thusu KG, Morin III FC, Russell JA, Steinhorn RH . The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Am J Respir Crit Care Med 1995; 152: 1605\u20131610.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFjp2008160_CR38","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1152\/jappl.1995.78.4.1288","volume":"78","author":"F Ichinose","year":"1995","unstructured":"Ichinose F, Adrie C, Hurford WE, Zapol WM . Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs. J Appl Physiol 1995; 78: 1288\u20131295.","journal-title":"J Appl Physiol"},{"key":"BFjp2008160_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00000542-199802000-00020","volume":"88","author":"F Ichinose","year":"1998","unstructured":"Ichinose F, Adrie C, Hurford WE, Bloch KD, Zapol WM . Selective pulmonary vasodilation induced by aerosolized zaprinast. Anesthesiology 1998; 88: 410\u2013416.","journal-title":"Anesthesiology"},{"issue":"2 Suppl","key":"BFjp2008160_CR40","doi-asserted-by":"publisher","first-page":"152S","DOI":"10.1378\/chest.88.2_Supplement.152S","volume":"88","author":"SP Newman","year":"1985","unstructured":"Newman SP . Aerosol deposition considerations in inhalation therapy. Chest 1985; 88 (2 Suppl): 152S\u2013160S. Review.","journal-title":"Chest"},{"issue":"11","key":"BFjp2008160_CR41","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s00134-003-2016-4","volume":"29","author":"C Stocker","year":"2003","unstructured":"Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS . Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med 2003; 29 (11): 1996\u20132003.","journal-title":"Intensive Care Med"},{"key":"BFjp2008160_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00000542-199907000-00041","volume":"91","author":"AM Atz","year":"1999","unstructured":"Atz AM, Wessel DL . Sildenafil ameliorates effects of inhaled nitric oxide withdrawl. Anesthesiology 1999; 91: 307\u2013310.","journal-title":"Anesthesiology"},{"key":"BFjp2008160_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1542\/peds.2006-2567","volume":"119","author":"M Martell","year":"2007","unstructured":"Martell M, Blasina F, Silvera F, Tellechea S, Godoy C, Vaamonde L . Intratracheal sildenafil in the newborn with pulmonary hypertension. Pediatrics 2007; 119: 215\u2013216.","journal-title":"Pediatrics"},{"issue":"3","key":"BFjp2008160_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1054\/plef.2001.0261","volume":"64","author":"M Tamura","year":"2001","unstructured":"Tamura M, Kurumatani H, Matsushita T . Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension. Prostaglandins Leukot Essent Fatty Acids 2001; 64 (3): 197\u2013202.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"BFjp2008160_CR45","doi-asserted-by":"publisher","first-page":"F214","DOI":"10.1136\/fn.71.3.F214","volume":"71","author":"L Bindl","year":"1994","unstructured":"Bindl L, Fahnenstich H, Peukert U . Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal Ed 1994; 71 (3): F214\u2013F216.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFjp2008160_CR46","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0022-3476(88)80701-7","volume":"112","author":"SJ Soifer","year":"1998","unstructured":"Soifer SJ, Clyman RI, Heymann MA . Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. J Pediatr 1998; 112: 774\u2013777.","journal-title":"J Pediatr"},{"key":"BFjp2008160_CR47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0014-2999(94)90340-9","volume":"260","author":"KW Buchan","year":"1994","unstructured":"Buchan KW, Magnusson KW, Rabe KF, Summer MJ, Watts IS . Characterization of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro46-2005. Eur J Pharmacol 1994; 260: 221\u2013226.","journal-title":"Eur J Pharmacol"},{"key":"BFjp2008160_CR48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000014163","volume":"76","author":"C Kuo","year":"1999","unstructured":"Kuo C, Chen J . Effect of meconium aspiration on plasma endothelin-1 level and pulmonary hemodynamics in a piglet model. Biol Neonate 1999; 76: 228\u2013234.","journal-title":"Biol Neonate"},{"key":"BFjp2008160_CR49","first-page":"420","volume":"100","author":"CY Kyo","year":"2001","unstructured":"Kyo CY . Endothelin\u2014a receptor antagonist prevents neonatal pulmonary hypertension in meconium aspiration in piglets. J Formos Med Assoc 2001; 100: 420\u2013423.","journal-title":"J Formos Med Assoc"},{"key":"BFjp2008160_CR50","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa012212","volume":"346","author":"LJ Rubin","year":"2002","unstructured":"Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A et al. Bosentan therapy for pulmonary arterial hypertension. N Eng J Med 2002; 346: 896\u2013903.","journal-title":"N Eng J Med"},{"key":"BFjp2008160_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1378\/chest.124.1.247","volume":"124","author":"O Sitbon","year":"2003","unstructured":"Sitbon O, Badesch DB, Channick RN, Frost A, Robbins IM, Simonneau G et al. Effects of dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest 2003; 124: 247\u2013254.","journal-title":"Chest"},{"key":"BFjp2008160_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1203\/01.pdr.0000191813.60977.bf","volume":"59","author":"R Geiger","year":"2006","unstructured":"Geiger R, Pajk W, Neu N, Maier S, Kleinsasser A, Fratz S et al. Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration. Pediatr Res 2006; 59: 147\u2013150.","journal-title":"Pediatr Res"},{"issue":"3","key":"BFjp2008160_CR53","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-201X.1997.00143.x","volume":"160","author":"P Kappa","year":"1997","unstructured":"Kappa P, Jahnukainen T, Grinlund J, Rautanen M, Halkola L, V\u00e4lim\u00e4ki I . Adenosine triphosphate treatment for meconium aspiration-induced pulmonary hypertension in pigs. Acta Physiol Scand 1997; 160 (3): 283\u2013289.","journal-title":"Acta Physiol Scand"},{"key":"BFjp2008160_CR54","first-page":"472","volume":"96","author":"TJ Wu","year":"1995","unstructured":"Wu TJ, Teng RJ, Tsou KI . Persistent pulmonary hypertension of the newborn treated with magnesium sulfate in premature neonates. Pediatrics 1995; 96: 472\u2013474.","journal-title":"Pediatrics"},{"issue":"4","key":"BFjp2008160_CR55","first-page":"373","volume":"8","author":"SK Patole","year":"1995","unstructured":"Patole SK, Finer NN . Experimental and clinical effects of magnesium infusion in the treatment of neonatal pulmonary hypertension. Magnes Res 1995; 8 (4): 373\u2013388. Review.","journal-title":"Magnes Res"},{"key":"BFjp2008160_CR56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/adc.67.1_Spec_No.31","volume":"67","author":"YK Abu-Osaba","year":"1992","unstructured":"Abu-Osaba YK, Galal O, Mansara K, Rejjal A . Treatment of severe persistent pulmonary hypertension of the newborn with magnesium sulphate. Arch Dis Child 1992; 67: 31\u201335.","journal-title":"Arch Dis Child"},{"issue":"3","key":"BFjp2008160_CR57","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/S0006-291X(88)81362-7","volume":"153","author":"RM Palmer","year":"1988","unstructured":"Palmer RM, Rees DD, Ashton DS, Moncada S . L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988; 153 (3): 1251\u20131256.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"BFjp2008160_CR58","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1164\/ajrccm.164.5.2010104","volume":"164","author":"RH Steinhorn","year":"2001","unstructured":"Steinhorn RH, Albert G, Swartz DD, Russell JA, Levine CR, Davis JM . Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am J Respir Crit Care Med 2001; 164 (5): 834\u2013839.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFjp2008160_CR59","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1542\/peds.103.5.1014","volume":"103","author":"BCC Lam","year":"1999","unstructured":"Lam BCC, Yeung CY . Surfactant lavage for meconium aspiration syndrome: a pilot study. Pediatrics 1999; 103: 1014\u20131018.","journal-title":"Pediatrics"},{"key":"BFjp2008160_CR60","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1203\/00006450-199612000-00010","volume":"40","author":"BK Rubin","year":"1996","unstructured":"Rubin BK, Tomkiewicz RP, Patrinos ME, Easa D . The surface and transport properties of meconium and reconstituted meconium solutions. Pediatr Res 1996; 40: 834\u2013838.","journal-title":"Pediatr Res"},{"key":"BFjp2008160_CR61","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1651-2227.1993.tb12635.x","volume":"82","author":"B Sun","year":"1993","unstructured":"Sun B, Curstedt T, Robertson B . Surfactant inhibition in experimental meconium aspiration syndrome. Acta Pediatr 1993; 82: 182\u2013189.","journal-title":"Acta Pediatr"},{"issue":"2","key":"BFjp2008160_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/ppul.1950170202","volume":"17","author":"KB al-Mateen","year":"1994","unstructured":"al-Mateen KB, Dailey K, Grimes MM, Gutcher GR . Improved oxygenation with exogenous surfactant administration in experimental meconium aspiration syndrome. Pediatr Pulmonol 1994; 17 (2): 75\u201380.","journal-title":"Pediatr Pulmonol"},{"key":"BFjp2008160_CR63","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1067\/mpd.2001.109602","volume":"138","author":"PA Dargaville","year":"2001","unstructured":"Dargaville PA, South M, McDougall PN . Surfactant and surfactant inhibitors in meconium aspiration syndrome. J Pediatr 2001; 138: 113\u2013115.","journal-title":"J Pediatr"},{"key":"BFjp2008160_CR64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1542\/peds.97.1.48","volume":"97","author":"RD Findlay","year":"1996","unstructured":"Findlay RD, Taeusch HW, Walther FJ . Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996; 97: 48\u201352.","journal-title":"Pediatrics"},{"key":"BFjp2008160_CR65","first-page":"9","volume":"121","author":"CS Bryan","year":"1967","unstructured":"Bryan CS . Enhancement of bacterial infection by meconium. Johns Hopkins Med J 1967; 121: 9\u201313.","journal-title":"Johns Hopkins Med J"},{"key":"BFjp2008160_CR66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.jp.7210774","volume":"22","author":"AI Eidelman","year":"2002","unstructured":"Eidelman AI, Nevet A, Rudensky B, Rabinowitz R, Hammerman C, Raveh D et al. The effect of meconium staining of amniotic fluid on the growth of Escherichia coli and group B Streptococcus. J Perinatol 2002; 22: 467\u2013471.","journal-title":"J Perinatol"},{"key":"BFjp2008160_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000081086","volume":"87","author":"HC Lin","year":"2005","unstructured":"Lin HC, Su BH, Tsai CH, Lin TW, Yeh TF . Role of antibiotics in management of non-ventilated cases of meconium aspiration syndrome without risk factors for infection. Biol Neonate 2005; 87: 51\u201355.","journal-title":"Biol Neonate"},{"key":"BFjp2008160_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF02753596","volume":"62","author":"V Shankar","year":"1995","unstructured":"Shankar V, Paul VK, Deorari AK, Singh M . Do neonates with meconium aspiration syndrome require antibiotics? Indian J Pediatr 1995; 62: 327\u2013331.","journal-title":"Indian J Pediatr"},{"issue":"5","key":"BFjp2008160_CR69","first-page":"529","volume":"32","author":"L Krishnan","year":"1995","unstructured":"Krishnan L, Nasruddin, Prabhakar P, Bhaskaranand N . Routine antibiotic cover for newborns intubated for aspirating meconium: is it necessary? Indian Pediatr 1995; 32 (5): 529\u2013531.","journal-title":"Indian Pediatr"},{"key":"BFjp2008160_CR70","doi-asserted-by":"publisher","first-page":"L785","DOI":"10.1152\/ajplung.00335.2001","volume":"283","author":"AM Khan","year":"2002","unstructured":"Khan AM, Elidemir O, Epstein CE, Lally KP, Xue H, Blackburn M et al. Meconium aspiration produces airway hyperresponsiveness and eosinophilic inflammation in a murine model. Am J Physiol Lung Cell Moll Physiol 2002; 283: L785\u2013L790.","journal-title":"Am J Physiol Lung Cell Moll Physiol"},{"issue":"3","key":"BFjp2008160_CR71","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF02724267","volume":"71","author":"A Zagariya","year":"2004","unstructured":"Zagariya A, Bhat R, Navale S, Vidyasagar D . Cytokine expression in meconium-induced lungs. Indian J Pediatr 2004; 71 (3): 195\u2013201.","journal-title":"Indian J Pediatr"},{"key":"BFjp2008160_CR72","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s004310000581","volume":"159","author":"A Zagariya","year":"2000","unstructured":"Zagariya A, Bhat R, Uhal B, Navale S, Freidine M, Vidyasagar D . Cell death and lung cell histology in meconium aspirated newborn rabbit lung. Eur J Pediatr 2000; 159: 819\u2013826.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"BFjp2008160_CR73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1203\/00006450-199908000-00009","volume":"46","author":"AM Khan","year":"1999","unstructured":"Khan AM, Shabarek FM, Kutchback JW, Lally KP . Effects of dexamethasone on meconium aspiration syndrome in newborn piglets. Pediatr Res 1999; 46 (2): 179\u2013183.","journal-title":"Pediatr Res"},{"key":"BFjp2008160_CR74","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s004310000678","volume":"160","author":"DE da Costa","year":"2001","unstructured":"da Costa DE, Nair AK, Pai MG, Al Khusaiby SM . Steroids in full term infants with respiratory failure and pulmonary hypertension due to meconium aspiration syndrome. Eur J Pediatr 2001; 160: 150\u2013153.","journal-title":"Eur J Pediatr"},{"key":"BFjp2008160_CR75","doi-asserted-by":"crossref","unstructured":"Ward M, Sinn J . Steroid therapy for meconium aspiration syndrome in newborn infants. Cochrane Database Syste Rev 2003; (4): CD003485. Review.","DOI":"10.1002\/14651858.CD003485"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp2008160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2008160","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2008160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T15:46:47Z","timestamp":1647618407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp2008160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":75,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFjp2008160"],"URL":"https:\/\/doi.org\/10.1038\/jp.2008.160","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"5 December 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}